BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Osmotica Pharmaceutical 

1205 Culbreth Drive
Suite 200
Wilmington  North Carolina  28405  U.S.A.
Phone: 910-509-0114 Fax: 910-509-0115


SEARCH JOBS




Industry
Pharmaceutical






 Company News
Osmotica Pharmaceutical Announces the Commercial Launch of Its KHEDEZLA (desvenlafaxine) Extended-Release Tablets, 50 mg and 100 mg 9/27/2013 9:34:19 AM
Osmotica Pharmaceutical Appoints Praveen Tyle, Ph.D. as President and CEO 1/4/2013 7:07:32 AM
Osmotica Pharmaceutical Announces Initiation of Phase III Studies With Arbaclofen ER Tablets 12/10/2012 9:41:50 AM
Osmotica Pharmaceutical Announces the Appointment of Praveen Tyle, PhD as Executive Vice President and Chief Scientific Officer 10/15/2012 10:17:24 AM
Osmotica Pharmaceutical and Panacea Biotech Ltd. Announce Strategic Alliance Agreement 9/11/2012 10:15:30 AM
Osmotica Pharmaceutical Announces the Appointment of Darren Alkins as Executive Vice President 9/10/2012 9:34:04 AM
Osmotica Pharmaceutical to Create 156 Jobs in Georgia 8/12/2011 7:39:36 AM
Osmotica Pharmaceutical and Upstate Pharma, LLC, a Subsidiary of UCB, Inc. (UCBJF.PK), Announce the Availability of Venlafaxine Extended-Release Tablets 10/9/2008 11:08:15 AM
Osmotica Pharmaceutical Announces The Successful Co-Development Of FDA-Approved Allegra-D 24-Hour Extended Release Tablets10/19/2005 5:12:03 PM
New Drug Application Approved For Once-Daily Allegra-D Formulation Using aaiPharma Inc.'s (AAII) Development Expertise10/19/2005 5:11:57 PM
12